Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Infectious Laryngotracheitis Vaccine (MEVAC)
- Development stage
- Unknown
- Lead developer
- MEVAC
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Ophthalmic, Inhalation, Oral
01
Overview
The Infectious Laryngotracheitis (ILT) Vaccine is a veterinary biologic developed by Middle East for Vaccines (MEVAC) for the active immunization of poultry against Gallid alphaherpesvirus 1. Infectious Laryngotracheitis is a highly contagious respiratory disease in chickens characterized by severe respiratory distress, coughing, and high mortality, leading to significant economic losses in the poultry industry. The vaccine is designed to stimulate the bird's immune system to produce a protective response, thereby reducing clinical signs and viral shedding within flocks. MEVAC, an American-Egyptian joint venture, produces this vaccine as part of its comprehensive range of poultry health solutions for the Middle East and African markets.
- Brand names
- MEVAC ILT
- Other names
- Infectious Laryngotracheitis VaccineILT Vaccine
Beyond the preview
Go deeper on Infectious Laryngotracheitis Vaccine (MEVAC).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Infectious Laryngotracheitis Vaccine (MEVAC).